PURPOSE. To identify recessive mutations affecting development and/or maintenance of the zebrafish visual system.
T he zebrafish, Danio rerio, has been increasingly used over the past 3 decades as a model system in which to study visual system development, ocular physiology, and visual system function, as well as one in which to study the molecular and cellular underpinnings of ocular diseases. [1] [2] [3] [4] [5] Indeed, capitalizing on the ability to perform large-scale forward genetic screens in the zebrafish system, researchers have identified numerous mutations that result in phenotypes similar to those in a variety of human ocular disorders (reviewed in Bibliowicz et al. 1 ). Analyses of these mutations have contributed to a better understanding of ocular diseases and processes that affect nearly every part of the eye, highlighting the efficacy of the approach, and the importance of the zebrafish model system in ocular research.
Although forward genetic screens have been performed using a variety of mutagens, the saturation of these screens has been low, and multiple alleles have been identified for only a few loci, supporting the notion that further screening is likely to identify additional mutations that affect the visual system, as well as additional alleles that will be useful in biochemical analyses of the proteins encoded by the affected loci. Moreover, given the recent advances in whole-genome sequencing, it is now possible to rapidly and cost-effectively identify the affected loci in mutant lines, enabling one to quickly target relevant mutations in ocular disease-causing genes for further study. [6] [7] [8] [9] With this in mind, we have recently completed an ENU (N-Nitroso-N-ethylurea)-based forward genetic screen to identify recessive mutations that affect eye morphology in zebrafish embryos up to 5 days postfertilization (dpf). Herein, we report the results of this screen and the identification and characterization of a new mutant allele of the zebrafish patched2 gene.
MATERIALS AND METHODS

Animals and Maintenance
Zebrafish (Danio rerio) were maintained at 28.58C on a 14-hour light/ 10-hour dark cycle. Embryos were obtained from the natural spawning of heterozygous carriers set up in pairwise crosses. Embryos were collected and raised at 28.58C after Westerfield, 10 and were staged according to Kimmel et al. 11 All animals were treated in accordance with provisions established at the University of Texas at Austin governing animal use and care, and adhered to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
ENU Mutagenesis
An ENU mutagenesis protocol was modified from Solnica-Krezel et al. 12 Briefly, 18 AB males were exposed to a freshly made 3-mM solution of ENU (Sigma ISOPAC, St. Louis, MO), buffered in a 1-mM sodium phosphate solution. Fish were exposed at a density 3 males/1 L of ENU solution, maintained at approximately 218C, and they remained in the solution for 1 hour. Fish were removed from the ENU solution, placed into fresh fish water, and maintained overnight in a dark, quiet area to recover. The following morning, they were placed back onto the aquatic system. ENU exposures were repeated weekly for 3 additional weeks, after which 9 mutagenized F0 males remained. These males were bred once to release any nonmutagenized sperm, and then they were outcrossed to AB females to generate F1s. F1s were either intercrossed, or outcrossed to wild-type ABs, to generate F2 families; 1 to 12 pairs of F2 fish per family were mated to generate F3 embryos for screening.
F3 Mutant Screening
F3 embryos were examined daily through 5 dpf under a dissecting microscope (Nikon SMZ800; Nikon, Melville, NY) to identify embryos with ocular defects. At 5 dpf, embryos were fixed and processed for cryosectioning after Uribe and Gross 13 ; 12-lm sections were taken from at least 5 embryos and stained with either hematoxylin and eosin (Sigma, St. Louis, MO) or Sytox-Green (Molecular Probes, Eugene, OR) to examine retinal and lens morphology and cellular organization. Putative F2 carriers were rescreened, and those that produced embryos resulting in reproducible ocular phenotypes were outcrossed to AB fish. Heterozygous carriers were then identified in these F3 lines and phenotypes verified, and then an F3 line was given an allele number and the mutation was considered ''recovered'' in the screen.
Riboprobes and In Situ Hybridization
Hybridizations were performed essentially as described by Jowett and Lettice 14 using digoxigenin-labeled antisense RNA probes. ptch2 cDNA and probes are described in Lee et al. 15 cDNA for pax2a was provided by Bruce Riley (Texas A&M University).
Cyclopamine Treatments
Cyclopamine (Sigma) was resuspended at 10 mg/mL in 100% ethanol and diluted into fish water for exposures; 100% ethanol was used for vehicle controls. Embryos derived from heterozygous uta 1 incrosses were used for all exposures. Embryos were removed from cyclopamine at defined times and washed into fish water for further culturing. Cyclopamine rescue data were analyzed by Fisher's exact test for statistical significance.
RESULTS
F3 Mutant Screen to Identify Recessive Ocular Mutations
To identify recessive zebrafish mutants with morphological defects in eye formation, a three-generation ENU-based forward genetic screen was performed (Fig. 1) . F3 embryos were screened under a dissecting microscope to identify those that possessed obvious defects in optic cup or lens morphology, eye size, RPE pigmentation, and/or lens transparency. Observations were also made with regard to the overall health of the F3 embryos, to eliminate F2 families that produced embryos that possessed significant nonocular defects, generalized growth defects, or increased levels of cell death, as ocular phenotypes in these lines would likely be secondary to more systemwide defects. At 5 dpf, a subset of F3 embryos from each F2 pair was fixed and processed for cryosectioning and imaging following either immunostaining with Sytox-Green (a DNA marker) or hematoxylin and eosin staining. Eye sections from these embryos were analyzed for defects in retinal lamination, the presence and organization of retinal cell types, and overall lens and cornea morphology. From the 126 F2 families screened, 18 mutants were isolated that displayed ocular defects (Table) . Mutants were identified with colobomas ( Figs 
uta 1 Mutants Possess Colobomas
We were particularly interested in identifying mutants with defects in choroid fissure closure, and, thus, those mutants that presented with colobomas. 16 Several coloboma mutants were identified in our primary screen. After further analysis, only two of these lines presented without additional, systemic defects and, thus, represented loci encoding gene products with potentially limited functions outside of the eye: uta 1 and uta 3 . Coloboma phenotypes in these mutants are similar at a gross histological level, although colobomas in uta 1 are more severe. uta 1 was of particular interest to us given that it did not appear to have any other obvious embryonic defects outside of the eye (Fig. 3) . In uta 1 mutants, the choroid fissure remained open and, as a result, retinal and RPE tissue are not contained within the eyecup (Figs. 3C-H). The severity of the phenotype is relatively invariant between homozygous embryos, with almost all presenting with severe, bilateral colobomas (Fig. 3H ). The incidence of colobomas ranges from 22% to 25% of total embryos in any given clutch derived from heterozygous parents, and this Mendelian ratio is consistent with a single gene mutation. Within the eye, beyond colobomas, other aspects of development and patterning appear overtly normal, although the eye is microphthalmic when viewed laterally, but this could be due to the presence of the coloboma.
Optic Vesicle Patterning Is Abnormal in uta 1 The overall phenotype of uta 1 resembled a coloboma mutant previously studied in our laboratory, blowout, which possesses a recessive mutation in the patched2 gene (ptch2 tc294z , formerly known as patched1 in zebrafish 15, 17 ). ptch2 tc294z mutants present with a visible expansion of the optic stalk at 1 dpf, and obvious colobomas at 2 dpf. Expansion of the optic stalk in ptch2 tc294z correlated with an expansion of the expression domain of the distal optic vesicle marker, pax2a, and optic stalk tissue resided within the choroid fissure, possibly preventing apposition of the lateral edges of the fissure, leading to colobomas in ptch2 tc294z mutants. 15 To determine if colobomas in uta 1 mutants also correlated with defects in optic vesicle patterning, we examined pax2a expression (Fig. 4) . Indeed, the domain of pax2a was substantially expanded relative to that in sibling control embryos at 30 hpf (Figs. 4A, 4B) . Moreover, at 48 hpf, concomitant with optic stalk differentiation, pax2a expression was almost absent from wild-type siblings, whereas in uta 1 mutants, expression was main- tc294z mutants possess a recessive mutation, ptch2 W1040X , that truncates the Ptch2 protein at amino acid 1039 in the Cterminus, just after the eighth transmembrane segment. 15, 17 Given the similarity in coloboma phenotypes and pax2a expression between uta 1 and ptch2 tc294z mutants, we next determined if uta 1 was a ptch2 allele. Complementation crosses between uta 1 and ptch2 tc294z resulted in embryos with colobomas, supporting the possibility that they were alleles of the same gene (data not shown). Cloning and sequencing of the ptch2 gene from cDNA derived from uta 1 mutants and wild-type siblings revealed a 57-bp internal deletion in the ptch2 open-reading frame that resulted in an in-frame deletion of 19 amino acids from the Ptch2 protein (Fig. 5A ). Cloning and sequencing of this region of the ptch2 gene from genomic DNA isolated from uta 1 mutants and wildtype siblings revealed a G A mutation at the intron 4 spliceacceptor site (Fig. 5B) . Reanalysis of cDNA sequences from exon 5 of the ptch2 gene identified a cryptic, in-frame spliceacceptor site whose use results in the removal of the first 57 bp of exon 5 (Fig. 5A) . The 19 amino acids absent from the Ptch2 uta1 protein are highly conserved between zebrafish, human, and mouse Ptch2 proteins, as well as with Ptch1 orthologs in each of these systems (Fig. 5C ). Based on the predicted structure/topology of the Ptch2 protein, 18 these 19 amino acids are predicted to contribute to the first extracellular loop of the protein (Fig. 5D) . Hereafter, we refer to uta 1 as ptch2 uta1 in accordance with zebrafish nomenclature guidelines.
Hh Pathway Activity Is Expanded in ptch2 uta1
Mutants
Patched2 is a negative regulator of the Hedgehog (Hh) pathway, functioning to inhibit Smoothened and thereby block Hh pathway activity in the absence of Hh ligands. When Patched function is deficient, Hh pathway activity is constitutively active in a ligand-independent manner, and Hh target gene expression is expanded. 19 To test this model in ptch2 uta1 mutants, ptch2 expression was examined, as this is a useful readout for Hh pathway activity. [19] [20] [21] [22] [23] In wild-type embryos, ptch2 is expressed in the optic stalk at 28 hpf (Figs. 6A, 6C) , as well as throughout the ventral brain and the somites 20 (data not shown). In ptch2 uta1 mutants, however, ptch2 expression appears in a substantially broader domain of expression in each of these regions (Figs. 6B, 6D ). These data support a model in which Hh pathway activity is expanded as a result of loss of Ptch2 function in ptch2 uta1 mutants.
To directly test the hypothesis that upregulation of Hh pathway activity is the molecular mechanism underlying colobomas in ptch2 uta1 mutants, we used cyclopamine, a pharmacological inhibitor of the Hh pathway that acts on Smoothened, downstream of the Patched receptor, 24, 25 and examined whether low doses of cyclopamine were capable of suppressing colobomas in ptch2 uta1 mutants, an assay that has been performed successfully with ptch2 tc294z mutants, 15 as well as with mutations in other negative regulators of the Hh pathway (e.g., ptch1/lep and Hip/uki 26 ). Low levels of cyclopamine (4 lM) did not lead to overt defects in eye development (Figs. 6E, 6F) ; however, exposure of ptch2 uta1 mutants to 4 lM of cyclopamine between 5.5 hpf and 24 hpf was completely effective in suppressing colobomas (Fig. 6G) . In vehicle-treated controls, 24.4% 6 1.3% possessed colobomas, whereas treatment with 4 lM cyclopamine completely suppressed the incidence of colobomas in mutant embryos (0%; n ¼ 3 biological replicates, P < 0.005). These data indicate that disrupted Hh signaling pathway activity likely underlies coloboma formation in ptch2 uta1 mutants.
DISCUSSION
We have performed a three-generation ENU mutagenesis screen in zebrafish to identify recessive mutations affecting development of the eye. Our screen identified 18 mutations that affected a variety of ocular tissues, and these mutants will be useful in better understanding the development and maintenance of these tissues, as well as the mechanistic underpinnings of congenital ocular diseases that affect them.
The most prevalent class of mutations identified in the screen was those that affected the formation of the lens and/or resulted in cataracts, with 10 such mutants recovered. Several detailed descriptions of zebrafish lens morphogenesis and the establishment of cell fates within the zebrafish lens have been published in the past few years, [27] [28] [29] and these, in combination with mutagenesis screens targeting lens mutants, highlight the utility of zebrafish in furthering our understanding of the mechanisms facilitating vertebrate lens development and cataractogenesis. Indeed, recent studies using zebrafish mutants have begun to elucidate roles for DNA methyltransferase activity during lens development, 30 and in vivo roles for the ubiquitin proteasome system during lens epithelial cell proliferation and lens fiber differentiation in zebrafish, 31 highlighting the utility of zebrafish in identifying novel components required for normal lens development and maintenance in vivo.
In addition to lens/cataract mutants, numerous other mutants with ocular phenotypes of interest were identified in the screen (i.e., microphthalmic mutants, mutants with photoreceptor defects, coloboma mutants, and oculocutaneous albinos). Each of these lines will be useful in modeling human congenital ocular disorders and thereby gaining mechanistic insight into the underlying cellular and molecular underpinnings of these diseases. Recent technological advances in zebrafish, using whole-genome sequencing and single nucleotide polymorphism mapping algorithms, have enabled the rapid mapping and cloning of recessive ENU mutations, eliminating in many cases the need for more time-consuming PCR-based positional cloning strategies. [6] [7] [8] [9] Historically, identification of the affected locus in zebrafish mutants has been the rate-limiting step in postscreen analysis of mutants; therefore, these recent advances in cloning techniques also promise to rapidly increase the number of cloned mutations, and thus the number of zebrafish ocular disease models. These advances will undoubtedly contribute to identifying mutations in zebrafish orthologs of previously unidentified disease-causing genes, but also to identifying additional alleles of existing mutations, which will facilitate in vivo structure-function analyses of the affected proteins.
With this latter point in mind, we have identified a new patched2 mutant allele, ptch2 uta1 , in which a splice-acceptor site mutation leads to an in-frame deletion of 19 amino acids from the Ptch2 protein. The deleted region of the protein is predicted to contribute to the first extracellular loop of Ptch2, and this loop is thought to function, in conjunction with the second extracellular loop, in binding of Hh ligands 32 (Fig. 5D ). Hh signaling regulates a number of diverse aspects of eye development, 33, 34 including two key developmental roles during early eye development. The first of these is in segregating the eye field into two bilateral optic vesicles (OVs), 35, 36 and the second is in promoting proximal OV fates (optic stalk, choroid fissure) at the expense of distal OV fates (retina, RPE, lens). Loss of Hh signaling results in holopro- sencephaly in human patients and animal models, 37, 38 whereas overexpression of Shh in a number of model systems results in expansion of proximal OV fates at the expense of distal ones. [39] [40] [41] [42] [43] ptch2 uta1 mutants possess an expansion of proximal fates (Fig. 4) and expanded Hh pathway gene expression (Fig.  6 ), supporting a model in which the ptch2 uta1 mutation leads to upregulated Hh pathway activity. Indeed, suppression of colobomas in these mutants by cyclopamine supports such a mechanism (Fig. 6G) . Two other ptch2 alleles have been identified in zebrafish, ptch2 tc294z and ptch2 hu1602 , and both of these also show elevated Hh pathway activity. 15, 17 In ptch2 uta1 and ptch2 hu1602 mutants, colobomas are highly penetrant, averaging 21% to 25% per clutch, whereas ptch2 tc294z is thought to be a hypomorphic allele due to the low penetrance of the colobomas, averaging 3% to 5% per clutch. 15, 17 Given the unique mutations in each of these alleles, and what has been learned from a number of biochemical studies on the Patched proteins, it is interesting to speculate on how these mutations might affect Ptch2 structure and function, and thereby influence Patched-dependent Hh pathway regulation. As discussed above, ptch2 tc294z mutants have a truncation of the Ptch2 protein just after the eighth transmembrane domain. The C-terminus of Patched mediates multimerization with other Patched subunits, with a trimeric complex of Patched thought to be the plasma membrane localized and physiological state of the receptor. 44 C-terminal deletions of Patched result in ligand-independent activation of the Hh pathway, 15, 17, 19 despite their ability to bind to Hh proteins, 19 supporting a model in which the C-terminus of Patched is required to inhibit Smoothened activity. The results of these studies suggest a model in which the low penetrance and hypomorphic nature of the ptch2 tc294z allele may be a result of the mutant protein only partially impairing the ability of the remaining subunits of the trimeric complex to interact with The 19 amino acids absent from ptch2 uta1 are predicted to contribute to the first extracellular loop of ptch2 (modified from Briscoe et al. 18 ). and inhibit Smoothened, or the emergence of phenotypes either when the trimeric complex contains two or three mutant subunits, or when a threshold number of trimeric complexes contain mutant subunits is surpassed, thereby preventing Smoothened inhibition in the absence of ligand. ptch2 uta1 and ptch2 hu1602 mutants, on the other hand, must behave in an entirely different mechanism, as the mutations are not predicted to disrupt the ability of the Ptch2 protein to interact with Smoothened. The ptch2 uta1 mutation removes a portion of the protein predicted to constitute part of the first extracellular loop that facilitates Hh binding, whereas the ptch2 hu1602 mutation inserts 27 amino acids into the protein, possibly also residing in this Hh-binding loop. 17 Deletion of either of the extracellular loops prevents Hh binding 32 ; moreover, deletion of most of the second loop of Patched (PtchD Loop2 ) results in a cell-autonomous dominant-negative blockade of Hh pathway activity in expressing cells. 18 Phenotypes in ptch2 uta1 and ptch2 hu1602 mutants represent a gain-of-function in Hh pathway activity (i.e., an expansion of pax2a and ptch2 expression, phenotypic rescue by cyclopamine exposure), however. Mechanistically, it is possible that the ptch2 uta1 encoded mRNA or protein is unstable, and that the ptch2 uta1 allele is a protein null. Our data do not support the former of these, as ptch2 uta1 mRNA is detected in mutant embryos by RT-PCR (Fig. 5) . No cross-reacting antisera have been identified that recognize zebrafish Ptch2 and therefore the latter of these possibilities cannot be ruled out. Alternatively, the ptch2 uta1 and ptch2 hu1602 mutations could be activating mutations, mimicking Hh binding, and relieving Patchedmediated inhibition of Smoothened activity in the absence of ligand. This would be interesting, as it would be informative in understanding how Hh binding is transduced through Patched to effect downstream signaling events in the Hh pathway. A detailed biochemical analysis of the mutant proteins will be required to address these possibilities in the future.
